Disclosed is the compound N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(2-hydroxy-2-methylpropylsulfonyl)-2-methylbenzamide. Further disclosed a composition which comprises the above compound, and a pharmaceutically acceptable carrier for the treatment of cancer in a mammal.